CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma · Stage III Pancreatic Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8 · Unresectable Pancreatic Ductal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Comprehensive Cancer Center, Duarte, California, United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
Contact: Principal Investigator (Farshid Dayyani)
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
Contact: Principal Investigator (Farshid Dayyani)
UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Study coordinator (Site Public Contact) · 720-848-0650
Contact: Principal Investigator (Alexis D. Leal)
Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
Contact: Principal Investigator (Mary F. Mulcahy)
Memorial Hospital East, Shiloh, Illinois, United States
Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
Contact: Principal Investigator (Patrick Grierson)
University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
Contact: Study coordinator (Site Public Contact) · 859-257-3379
Contact: Principal Investigator (Reema A. Patel)
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
Contact: Principal Investigator (Ana D. De Jesus Acosta)
National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States
Contact: Study coordinator (Site Public Contact) · 800-411-1222
Contact: Principal Investigator (Jibran Ahmed)
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
Contact: Principal Investigator (Patrick Grierson)
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
Contact: Principal Investigator (Patrick Grierson)
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
Contact: Principal Investigator (Patrick Grierson)
Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
Contact: Principal Investigator (Patrick Grierson)
Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
Contact: Principal Investigator (Patrick Grierson)
NYU Langone Hospital - Long Island, Mineola, New York, United States
Contact: Study coordinator (Site Public Contact) · cancertrials@nyulangone.org · 212-263-4432
Contact: Principal Investigator (Kristen R. Spencer)
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
Contact: Principal Investigator (Kristen R. Spencer)
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
Contact: Principal Investigator (Davendra P. Sohal)
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
Contact: Principal Investigator (Shafia Rahman)
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
Contact: Principal Investigator (Davendra P. Sohal)
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
Contact: Principal Investigator (Susanna V. Ulahannan)
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Site Public Contact) · 412-647-8073
Contact: Principal Investigator (Janie Y. Zhang)
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
Contact: Principal Investigator (Monica A. Patel)
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
Contact: Principal Investigator (Monica A. Patel)

Study leads

Patrick Grierson
Principal Investigator
Yale University Cancer Center LAO

View source on ClinicalTrials.gov